Archived from the original on 21 March 2011
Services and treatments not offered in every state, include medical treatment of overweight and obesity including lifestyle counseling (e.g., diet and exercise) and prescription medications, if clinically appropriate, based on completion of required consultation
| Weeks | Dose | Purpose | |---|---|---| | 1 to 4 | 0.25 mg once weekly | Tolerability induction | | 5 to 8 | 0.5 mg once weekly | Minimum effective therapeutic dose | | 9 to 12 (optional) | 1.0 mg once weekly | Enhanced glycemic control | | 13 to 16 (optional) | 1.7 mg once weekly | Bridge to maximum dose | | 17+ (optional) | 2.0 mg once weekly | Maximum approved dose for T2D | Dose advancement is not mandatory at every step
It can even include life-saving surgeries for some patients
We work with: Research laboratories
The stimulation index, which indicates the ability of insulin secretion to respond to glucose stimulation, was calculated by dividing the insulin concentration at high glucose by that at low glucose
